Advanced Drug Delivery Reviews: Difference between revisions
CSV import |
CSV import |
||
| Line 36: | Line 36: | ||
{{Pharma-stub}} | {{Pharma-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 03:22, 17 March 2025
Advanced Drug Delivery Reviews is a peer-reviewed academic journal that focuses on the latest research and development in drug delivery and pharmacotherapy. The journal is published by Elsevier and was first established in 1986.
Overview[edit]
Advanced Drug Delivery Reviews provides comprehensive and in-depth reviews of the latest advancements in drug delivery systems. The journal covers a wide range of topics, including nanotechnology, biomaterials, pharmaceutical science, biophysics, and bioengineering. The aim of the journal is to provide a platform for scientists and researchers to share their findings and contribute to the advancement of drug delivery technologies.
Scope[edit]
The scope of Advanced Drug Delivery Reviews is broad and encompasses all aspects of drug delivery, from the design and synthesis of delivery systems to their applications in disease treatment. The journal publishes reviews on topics such as controlled release, targeted delivery, nanomedicine, gene therapy, and tissue engineering.
Impact Factor[edit]
According to the Journal Citation Reports, the journal has a 2019 impact factor of 13.660, ranking it 2nd out of 267 journals in the category "Pharmacology & Pharmacy".
Editorial Board[edit]
The editorial board of Advanced Drug Delivery Reviews consists of distinguished scientists and researchers from around the world. The board is responsible for maintaining the high quality of the journal's content and ensuring that all published articles meet the journal's rigorous standards.
See Also[edit]
References[edit]
<references group="" responsive="1"></references>
